Doctor Practice Financing – Click Here for 100 percent financing for doctors starting up a practice or acquiring one!

Call: 904-551-6090

As you decide to start this important personal process, you will be required to create a detailed business plan that will include all the required elements for the medical practice. This formulated business plan will be of use to us so that we can be able to assess your general operation. You will be pleased to know that as lenders we are dedicated to undertake a fair assessment process of your plan so that we can effectively provide for the required finances that will be sufficient to handle all the initial company processes. With the cash-flow project that will be reflected by your business plan, you will be set to obtain a reasonable amount to money for your medical practice.

Read The Interesting Snippets Below For Exciting Health-Care News!

EU finds 'morning after pills' work, regardless of a woman's weight

– http://www.reuters.com

LONDON, July 24 (Reuters) – Emergency contraceptives, known as the “morning after pill”, remain suitable for all women who need them, regardless of a woman’s weight, European regulators said on Thursday.

Continue Reading On http://www.reuters.com »

Celgene profit rises 25 pct up on higher cancer drug sales

– http://www.reuters.com

July 24 (Reuters) – Celgene Corp reported a 25 percent increase in quarterly profit, helped by robust sales of its flagship cancer drug, Revlimid.

Continue Reading On http://www.reuters.com »

BRIEF-Biotie Therapies clinical study with BTT1023 awarded external grant funding

– http://www.reuters.com

July 24 (Reuters) – Biotie Therapies Oyj : * Says clinical study with Biotie’s BTT1023 in primary sclerosing cholangitis

Continue Reading On http://www.reuters.com »

U.S. paves way for Novartis to copy Amgen biotech drug

– http://www.reuters.com/healthNews

(Reuters) – U.S. regulators have accepted an application by Sandoz – the generics arm of Novartis – seeking approval for a copycat version of Amgen’s drug Neupogen, or filgrastim, for patients with low white blood cell counts.

Continue Reading On http://www.reuters.com/healthNews »

Atox Bio raises $23 million to fund flesh-eating bacteria treatment

– http://www.reuters.com/healthNews

TEL AVIV (Reuters) – Israel-based Atox Bio, a developer of therapeutics for severe infections, said on Thursday it has raised $23 million in an investment round led by SR One, the healthcare venture capital fund of GlaxoSmithKline.

Continue Reading On http://www.reuters.com/healthNews »

Paracetamol no better than placebo for low back pain, study finds

– http://www.reuters.com/healthNews

LONDON (Reuters) – Paracetamol, a painkiller universally recommended to treat people with acute low back pain, does not speed recovery or reduce pain from the condition, according to the results of a large trial published on Thursday.

Continue Reading On http://www.reuters.com/healthNews »